[ad_1] In their third quarter 2023 earnings call, biotechnology company REGENXBIO announced an updated strategic plan, positive clinical data from priority programs, and a corporate restructuring plan. The company is…
[ad_1] In their third quarter 2023 earnings call, biotechnology company REGENXBIO announced an updated strategic plan, positive clinical data from priority programs, and a corporate restructuring plan. The company is…